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are extensively studied. Such analyses have deﬁned general principles that govern the hepatic
regenerative response and implicated speciﬁc extracellular and intracellular signals as regulated during
and essential for normal liver regeneration. Nevertheless, the most proximal events that stimulate liver
regeneration and the distal signals that terminate this process remain incompletely understood. Recent
data suggest that the metabolic response to hepatic insufﬁciency might be the proximal signal that
initiates regenerative hepatocellular proliferation. This review provides an overview of the data in
support of a metabolic model of liver regeneration and reﬂects on the clinical implications and areas for
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This article is part of a review series on liver pathobiology.Liver diseases have a signiﬁcant impact on human mor-
bidity and mortality. Although disease-speciﬁc therapies
exist for some insults, in all cases of liver injury host sur-
vival and recovery depends upon the liver’s remarkable
capacity to regenerate. Therefore, liver regeneration has
been subjected to rigorous experimental investigation for
decades1e3 with hope that mechanistic insights provided by
such research will lead to novel, proregenerative strategies
with which to improve the management of human liver
diseases. Such analyses show that hepatic regenerative
capability is conserved in all vertebrates where it has been
studied, from ﬁsh to human, presumably because of the
essential metabolic, synthetic, and detoxiﬁcation functions
subserved by liver. Although other body structures also
regenerate in lower vertebrates (eg, the amputated ﬁn of
zebra ﬁsh), the liver is unique among mammalian visceral
organs in the ability to recover from injury by regeneration
instead of scar formation. Thus, elucidating the mechanisms
that regulate hepatic regeneration might also inform efforts
to promote regeneration in other human organs.
The best-characterized and most commonly used experi-
mental paradigm for investigating the molecular, cellular,
and physiological mechanisms that control liver regenera-
tion has been surgical resection of a portion of the rodentstigative Pathology.
.liver.4 In the most typically used version of this model (ie,
two-thirds partial hepatectomy), the anesthetized rodent
undergoes midventral laparotomy with sequential ligation
and resection of the left and median hepatic lobes, followed
by closure of the surgical wounds and recovery.5 Afterward,
a liver-speciﬁc regenerative response ensues, which includes
activation of speciﬁc extracellular and intracellular signals,
followed by alterations in gene and protein expression.
These events, in turn, direct previously quiescent hepato-
cytes and other cells in the remnant liver to reenter the cell
cycle and proliferate, ultimately leading to restoration of the
preresection liver/body mass ratio and normalization of
hepatic function. Subsequently, hepatic lobular architecture,
temporarily distorted by the regenerative response, is re-
modeled, and the liver returns to its preregenerative state
of proliferative inactivity.1e3 Nonsurgical animal models,
Huang and Rudnickbased on controlled exposure to hepatotoxins (eg, carbon
tetrachloride, thioacetamide, acetaminophen, and D-galac-
tosamine6) or genetically induced hepatocellular injury (eg,
the PiZ transgenic mouse model of a1-antitrypsin deﬁciency
liver disease7), have also been studied to further elucidate
the regulation of injury-induced hepatocellular proliferation
and liver regeneration, with some of the regenerative signals
identiﬁed in the partial hepatectomy model conserved in
those paradigms.8,9
Experimental analyses using the models described above
have deﬁned several common characteristics of the typical
hepatic regenerative response. For example, such studies
show that the liver/body mass ratio, which is precisely
regulated in health, is speciﬁcally restored by regeneration
after hepatic injury.1e4 This observation infers the existence
of a master regulator of the liver/body mass ratio (ie, a
hepatostat).1e3 Interestingly, a recent report demonstrated
that myostatin-null mice, which have skeletal muscle hy-
pertrophy, exhibit a reduced liver/body mass ratio compared
with wild-type littermates. That ﬁnding indicates that he-
patic mass is not regulated in proportion to skeletal muscle
mass, thereby illustrating a previously unrecognized degree
of extrahepatic tissue speciﬁcity to liver mass regulation.10
Analyses of liver regeneration have also revealed the
seemingly unlimited proliferative potential of quiescent
hepatocytes,3 and established that these cells are the source
from which recovered liver mass typically derives during
regeneration.11 Thus, liver regeneration does not necessarily
depend on a stem cell; however, bipotential liver stem cells
can be induced to expand within the liver under speciﬁc
experimental circumstances.12 These oval cells, named after
their histological appearance, also have been identiﬁed in
human liver diseases.13
The speciﬁc molecular mechanisms that control liver
regeneration also have been experimentally examined. The
importance of circulating factors in such regulation was ﬁrst
established by parabiotic analyses of regeneration,14,15 and
further suggested by the observation that periportal hepato-
cytes, which are closest to the afferent hepatic portal and
systemic blood supplies, proliferate before centrilobular he-
patocytes (furthest from those blood supplies) during this
response.16 Those observations motivated (still ongoing) ef-
forts to discover these humoral factors and their intracellular
targets. Such analyses have identiﬁed cytokines (eg, tumor
necrosis factor a and IL-6), growth- and matrix-derived fac-
tors (eg, hepatocyte growth factor and epidermal growth
factor receptor ligands), secondary messenger cascades and
other intracellular events (eg, Wnt-dependent b-catenin
signaling), transcription factors [eg, NF-kB, STAT3, cAMP
regulatory element-binding protein, CCAAT-enhancer
binding protein (C/EBP) b, activator protein 1, farnesoid X
receptor (FXR), and liver X receptor (LXR)], and other sig-
nals as highly regulated in response to resection- or toxin-
induced hepatic insufﬁciency.1e3 Moreover, analyses of
animal models in which these signals have been pharmaco-
logically or genetically manipulated have demonstrated their310functional importance during hepatic regeneration.1e3 After
recovery of hepatic mass, architecture, and function, liver
regeneration ceases. Although less well studied, speciﬁc
factors (eg, transforming growth factor b,1e3 integrin-linked
kinase,17 and glypican 318) have been implicated in the pre-
cision with which regeneration is terminated after restoration
of normal liver/body mass ratio. Nevertheless, despite the
broad knowledge gained from these studies, the nature and
identities of the most proximal events that initiate liver
regeneration and those distal signals that terminate this pro-
cess remain incompletely deﬁned, and the essence of the
hepatostat is still essentially unknown.
Rodents subjected to partial hepatectomy or exposed to
hepatotoxic substances develop stereotypical alterations in
hepatic and systemicmetabolism.19 These changes, which are
among the earliest events to occur in response to experi-
mentally induced hepatic insufﬁciency, begin with marked
alterations in glycemia, followed by changes in circulating
and hepatic metabolite levels. The functional importance of
such changes for liver regeneration is implied by several
experimental observations. For example, disruption of normal
metabolism precedes the onset of regenerative hepatocellular
proliferation and resolves with restoration of normal liver
mass (Figure 1). Furthermore, various experimental strategies
that suppress speciﬁc aspects of these metabolic alterations
impair the ensuing hepatic regenerative response (Figure 2).
This review summarizes and considers these data and other
evidence in support of ametabolicmodel of liver regeneration
in which the alterations in metabolism that occur in response
to liver injury promote regenerative hepatocellular prolifera-
tion (Figure 3).The Metabolic Response to Hepatic
Insufﬁciency
After experimentally induced sublethal hepatic injury, the
liver continues to perform essential metabolic and other
functions necessary for survival. Still, many studies show
that hepatic and systemic metabolism are rapidly and spe-
ciﬁcally altered in response to such regenerative stimuli
(Figure 1).19 For example, within hours of surgery, mice
subjected to partial hepatectomy develop signiﬁcant hypo-
glycemia compared with controls (Figure 1).20 This ﬁnding,
consistent with the essential role of liver in systemic glucose
homeostasis, likely results (at least in part) from the acute
removal of two-thirds of hepatic glycogen content and
gluconeogenic capacity. Moreover, these data indicate that
the liver does not entirely compensate for the acute hepatic
functional compromise induced in mice and perhaps other
animal models of regeneration; nonetheless, some adapta-
tion after partial hepatectomy does occur, including induc-
tion of hepatic gluconeogenic machinery and suppression of
liver glycolytic activity.21 Those changes, which are deter-
mined, in part, via transcriptional regulation,22 limit the
post-hepatectomy decline in blood glucose but at theajp.amjpathol.org - The American Journal of Pathology
Figure 1 The metabolic and hepatocellular
proliferative responses to partial hepatectomy.
Blood glucose, indexed body mass, hepatic triglyc-
eride content, liver/body weight ratio, plasma free
fatty acids, percentage hepatocellular bromodeox-
yuridine (BrdU) incorporation, and hepatocellular
mitotic frequency per high-powered ﬁeld (HPF; A)
and liver histological features (H&E) and BrdU
immunohistochemistry (B) at serial times after
partial hepatectomy (black circles) or sham (white
circles) surgery in mice. Scale barZ 100 mm.
Metabolism and Liver Regenerationexpense of glucose-derived hepaticATPproduction.Glycogen
in the remnant liver is also depleted in the hours after partial
hepatectomy.23 By 12 hours after surgery, animals exhibit a
systemic catabolic response, characterized by declining lean-
and adipose-tissue mass.24 Systemic fat depletion also occurs
in hepatotoxin-induced liver regeneration.25 From 12 to 24
hours after surgery, marked steatosis develops in the regener-
ating mouse liver (Figure 1).26 As with altered glycemia, liver
triglyceride accumulates coincidentally with hepatic induction
of an adipogenic transcriptional program.26 Several observa-
tions suggest that this transient steatosis results from uptake by
the regenerating liver of adipose-derived fat stores: i) serum
free fatty acids, derived from hypoglycemia-induced adipose
lipolysis, are signiﬁcantly elevated in animals subjected to
partial hepatectomy, compared with shameoperated controls,
prior to accumulation of hepatic fat in regenerating liver
(Figure 1),19 ii) fatty liver dystrophy (ﬂd) mice, which have aThe American Journal of Pathology - ajp.amjpathol.orggenetic mutation (in Lipin1), resulting in a paucity of systemic
adipose tissue, accumulate signiﬁcantly less liver fat after
partial hepatectomy than do their littermate controls,24 and iii)
suppression of de novo hepatic lipogenesis (by liver-speciﬁc
genetic disruption of fatty acid synthase expression) does
not prevent resection-induced hepatic steatosis.27 Over this
same time span, speciﬁc gluconeogenic-, ketogenic-, branched
chain-, and urea cycleerelated amino acids, likely derived
from systemic proteolysis, also appear in the serum and accu-
mulate in regenerating liver.28 Hepatic ATP content coinci-
dentally declines and AMP increases in the post-resection
liver remnant,29 with b-oxidation of fatty acids serving as
the predominant source of new ATP production in regener-
ating liver.19,30 These metabolic alterations precede the
onset of resection- or toxin-induced hepatocellular prolifera-
tion, which is subsequently promoted by induction of
cyclin expression and activation of cyclin-CDK complexes.31311
Figure 2 Evidence for the functional importance of the metabolic response to hepatic insufﬁciency during liver regeneration. Summary of the experimental
manipulations of metabolism reported to inﬂuence liver regeneration that are discussed in the text.
Huang and RudnickIn mice, peak hepatocellular DNA replication, one marker of
such proliferation, occurs 36 hours after partial hepatectomy,
with maximum hepatocellular mitotic progression taking
place 48 to 72 hours after liver resection (Figure 1). As
regeneration proceeds, these perturbations in hepatic and
systemic metabolism resolve. For example, hepatic triglyc-
eride levels decline with onset of hepatocellular proliferation,
and blood glucose and body mass return toward normal as
regenerative recovery of the liver/body mass ratio progresses
(Figure 1).20,24,26
The Functional Importance of Altered
Metabolism during Liver Regeneration
In addition to deﬁning the metabolic response to hepatic
insufﬁciency, experimental observations have implicated
these perturbations as important physiological determinants
of normal liver regeneration (Figure 2). Several examples
are considered here:
The Metabolic and Hepatocellular Proliferative
Responses to Partial Hepatectomy
Two-thirds partial hepatectomy results in signiﬁcantly
increased hypoglycemia, a greater decline in systemic body
mass and adipose stores, and higher accumulation of hepatic
triglyceride, as well as more robust hepatocellular prolifera-
tion, than does one-third hepatectomy.24 Thus, the metabolic
and hepatocellular proliferative responses to liver injury
occur in proportion to each other, at least over a certain range.
However, published experimental analyses of subtotal hep-
atectomy, in which 85% to 90% of the native liver is resected,
show delayed and impaired liver regeneration and increased
mortality.32,33 Those data suggest that liver regeneration
cannot rescue an animal below a threshold amount of
remnant liver mass (and function), at least without additional312support. This consideration has potential clinical relevance in
acute liver failure (ALF) and small (transplanted liver graft)
for (host) size syndrome (SFSS), as discussed further in
Subtotal Hepatic Resection under Clinical Implications.Glucose Supplementation Impairs Liver Regeneration
The functional importance of hypoglycemia during liver
regeneration has been demonstrated by several studies
showing suppression of liver resectione or hepatotoxin-
induced hepatocellular proliferation by enteral or parenteral
glucose supplementation.20,30 Glucose supplementation also
suppresses regeneration-associated hepatic fat accumula-
tion.30 Consistent with these data, dietary caloric restriction
accelerates initiation of regenerative hepatocellular prolifera-
tion.6,34 Themechanisms responsible for these effects havenot
been completely elucidated, although some progress has been
made. For example, a recent study showed that supplemental
glucose augments hepatic expression of C/EBPa, whose level
and activity normally decline during early regeneration.20 That
study also reported increased hepatic expression of the CDK
inhibitors, p21Cip1 and p27Kip1, in glucose-supplemented
animals. Nonetheless, the precise mechanisms by which sup-
plemental glucose increases the expression of these anti-
proliferative factors in regenerating liver remain undeﬁned.
As expected, circulating insulin levels decline in response
to partial hepatectomy-induced hypoglycemia and are aug-
mented by exogenous glucose supplementation.20 Conversely,
systemic diversion of portal circulation (eg, portacaval shunting,
which diverts pancreas-derived insulin away from the liver)
causes atrophyof the liver lobe fromwhich suchﬂow is diverted,
and insulin supplementation reverses such atrophy.35 Thus, the
functional role of alterations in glycemia and associated changes
in hepatic insulin (and, perhaps, other hormonal) signaling
during liver regeneration deserve further clariﬁcation. The
glucose supplementation regimens used in previously describedajp.amjpathol.org - The American Journal of Pathology
Figure 3 A metabolic model of liver regeneration. Summary of the candidate molecular mechanisms that link altered metabolism and regulation of liver
regeneration that are discussed in the text.
Metabolism and Liver Regenerationstudies of impaired liver regeneration do not entirely prevent
hypoglycemia; moreover, they reduce, but do not completely
abrogate, hepatocellular proliferation after partial hepatec-
tomy.20 Thus, the development of an experimental paradigm
with which euglycemia is maintained in the setting of hepatic
insufﬁciencymight further informmechanistic understanding of
the links between glycemia and liver regeneration.Nevertheless,
when considered collectively, these observations convincingly
establish such metabolic alterations as involved in the initiation
of liver regeneration.
Preventing Hepatic Fat Accumulation Suppresses Liver
Regeneration
The impact of preventing hepatic steatosis, after partial hepa-
tectomy and in other liver injury models, on the ensuing
regenerative response has also been investigated.Whenhepatic
fat accumulation is suppressed pharmacologically (eg, with
cloﬁbrate,36 supraphysiological leptin supplementation,26 or
propranolol37) or genetically (eg, as in ﬂd- or liver-speciﬁc
glucocorticoid receptor-knockout mice), liver regeneration is
inhibited.24,26 However, other studies using different mouse
models have reported seemingly contradictory results. For
example, liver regeneration in caveolin 1enull mice, in which
partial hepatectomyeinduced hepatic steatosis is reduced, was
reported to be impaired in one study but normal in another
study.38,39 Furthermore, hepatic triglyceride accumulation is
diminished but regeneration proceeds normally after partial
hepatectomy in liver fatty acid binding proteinenull mice
and in mice with intestine-speciﬁc deletion of the microsomalThe American Journal of Pathology - ajp.amjpathol.orgtriglyceride transfer protein.27 More important, liver resec-
tioneinduced hepatic fat accumulation was not entirely abro-
gated in either of those models, leading the investigators to
speculate about the existence of a “threshold of adaptive lipo-
genesis” essential for regeneration but not crossed in those
mice.27 Nonetheless, when taken together with data showing
that fat accumulates concomitantly with cell proliferation in
primary hepatocyte culture,40 these observations suggest that
hepatocellular lipid accumulation promotes hepatocyte prolif-
eration, at least under certain circumstances. Indeed, it has
even been speculated that the anti-regenerative effect of
glucose supplementation might be secondary to the suppres-
sive action of such intervention on release of free fatty acids
from systemic adipose.30 Consistent with this consideration,
both dietary and parenteral administration of various lipid-
based formulations accelerates resection-induced30 and toxin-
induced6 hepatocellular proliferation in experimental animals.
Interestingly, as with inhibition of liver regeneration by
glucose supplementation, the impaired regenerative response
associated with reduced hepatic fat accumulation in ﬂd mice
is associated with augmented hepatic p21Cip1 expression.20,24
Amino Acid Metabolism and Liver Regeneration
Altered amino acid metabolism also occurs during and might
inﬂuence normal liver regeneration. For example, a recent
report showed that a-NH2-butyric acid (Aab) accumulates in
serum and liver after partial hepatectomy in mice.28 Aab is
generated by transamination of 2-oxobutyrate, which is pro-
duced by methionine and threonine catabolism.41 Methionine313
Huang and Rudnickis primarily metabolized in the liver, and such metabolism is
commonly deranged in chronic liver disease.42 Furthermore,
hepaticmetabolismof S-adenosyl-methionine (SAMe),which
is synthesized from methionine by methionine-adenosyl
transferase 1A (MAT1A), is highly regulated during liver
regeneration, and such regulation is disrupted in experimental
and clinical liver disease and liver cancer.42 Interestingly,
perturbations in methionine metabolism induced by genetic
disruption of MAT1A expression inhibit mouse liver regen-
eration.43 Together, these ﬁndings suggest a correlation be-
tween increased metabolic ﬂux from methionine to Aab and
the initiation of liver regeneration. Other studies showed that
the speciﬁc activities of (predominantly periportal) urea cycle
and (primarily centrilobular) glutamine synthase enzymes are
down-regulated during liver regeneration44,45 and that phar-
macological inhibition of hepatic neutral amino acid uptake
impairs regeneration.46 Finally, provision of supplemental
branched-chain amino acids (BCAAs) was reported to pro-
mote liver regeneration in several studies.47 Taken together,
these observations implicate hepatic insufﬁciency-induced
alterations in uptake and metabolism of amino acids as
another aspect of the metabolic response to hepatic insufﬁ-
ciency, with functional importance during regenerative he-
patocellular proliferation.Candidate Molecular Mediators Linking
Metabolism and Liver Regeneration
The previously summarized data (Figure 2) link alterations
in metabolism to the regulation of liver regeneration but do
not deﬁne the speciﬁc responsible molecular mechanisms.
One possibility is that the metabolic response to hepatic
insufﬁciency provides the liver with substrates necessary to
meet the energy requirements of the hepatic regenerative
response while simultaneously accommodating the glucose
demands of the body mass. The liver might also meet sys-
temic energy demand via ketone body synthesis. However,
serum and hepatic levels of ketone bodies reportedly decline
during experimental liver regeneration.48,49 These changes
in ketone metabolism, like those of glycemia and lipid
metabolism, are accompanied by concordant changes in
transcriptional regulation, with expression of the ketogenic
enzyme, HMG-CoA synthase, down-regulated in regener-
ating liver.50 Not exclusive of these considerations, the
changes in metabolism that occur during liver regeneration
are likely to generate anabolic precursors (nucleotides,
amino acids, and lipids) necessary for the macromolecular
biosynthetic requirements of regenerative cell proliferation.
Consistent with this idea, the level of the less-active M2
isoform of the glycolytic enzyme pyruvate kinase (PK) in-
creases, whereas that of the more active PK-L isoenzyme
decreases, in regenerating liver.51 This switch should divert
glucose-derived carbon from glycolytic production of ATP to
macromolecule precursor synthesis (or back to glucose).
Increased PK-M2 is also associated with the Warburg effect,314ie, the aerobic glycolysis characteristic of cancer cell prolif-
eration.52 Together, these considerations suggest that alter-
ations in metabolism contribute to both the energy and
macromolecular precursor demands of the hepatic regener-
ative response. However, this conclusion does not explain the
inhibitory effect of supplemental glucose on liver regenera-
tion, nor can it account for the precision with which liver/
body mass ratio is restored by regeneration after hepatic
injury. Those observations, in particular, support the idea that
the metabolic response to hepatic insufﬁciency is itself the
source of a proregenerative signal. Although the speciﬁc
molecular mediators connecting metabolism and regenera-
tion await deﬁnitive identiﬁcation, we discuss several
attractive candidates speciﬁcally suggested by experimental
analyses of hepatocellular proliferation (Figure 3).
Insights from Analysis of Xenobiotic-Induced
Hepatocellular Proliferation
One candidate mechanistic link between metabolism and liver
regeneration is suggested by analyses of chemical mitogen-
induced hepatocellular proliferation.Administration of certain
xenobiotic compounds to rodents has long been recognized to
induce hepatocellular hypertrophy and hyperplasia, thereby
increasing liver mass in the absence of liver injury.53 With-
drawal of such agents is followed by a return to normal liver
mass, providing additional evidence for the hepatostat. During
the past two decades, several nuclear receptor transcription
factors have been identiﬁed as speciﬁc and direct mediators of
such xenobiotic-induced hepatocellular proliferation. For
example, peroxisome proliferator-activated receptor (PPAR)
a expression is required for development of the hepatomegaly
that occurs in rodents exposed to cloﬁbrate andWy-14,636.54
Similarly, the increase in liver mass that occurs with
administration of 1,4-bis[2-(3,5-dichloropyridoxyloxy)] ben-
zene (TCPOBOP) or phenobarbitol depends on the constitu-
tive androstane receptor (CAR55). Interestingly, partial
hepatectomye and toxin-induced liver regeneration is altered
in several models in which the expression or activity of certain
xenobiotic-activated transcription factors has been mani-
pulated. Moreover, analyses in mouse models in which
hepatic integrin-linked kinase or glypican 3 expression is
altered show that these signals, implicated in terminating
regeneration after partial hepatectomy,17,18 similarly affect
at least some models of xenobiotic-induced hepatocellular
proliferation.56e58 Thus, the mechanisms that regulate
chemically induced hepatomegaly overlap, at least to some
degree, with those that direct hepatic insufﬁciencyeinduced
liver regeneration. Conversely, disruption of other speciﬁc
upstream signals implicated in partial hepatectomyein-
duced liver regeneration does not necessarily prevent
xenobiotic-dependent changes in liver mass,59e61 indicating
that these chemically activated pathways can act down-
stream of or in parallel to at least some of the signals that
promote such regeneration. Even so, characterization of
hepatocellular proliferation and liver regeneration in modelsajp.amjpathol.org - The American Journal of Pathology
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responsive transcription factors has provided additional
insight into the mechanisms that might link metabolism to
liver regeneration. The following are some examples.
PPARa Data
A speciﬁc role for PPARa expression during normal liver
regeneration remains controversial based on conﬂicting re-
ports about the magnitude of derangement of regeneration in
PPARa-null mice.27,62e64 Nevertheless, recent data impli-
cating endogenous lipid metabolites as ligand activators of
PPARa65 raise the possibility that these and other naturally
occurring PPARa ligands might link transient hepatic lipid
accumulation after partial hepatectomy to subsequent initi-
ation of regenerative hepatocellular proliferation. These data
also suggest that other metabolites that accumulate in
regenerating liver might serve as speciﬁc endogenous li-
gands for additional xenobiotic-binding transcription factors
and, thereby, regulate liver regeneration.
FXR Data
FXR is a bile acideactivated transcriptional regulator, and
global disruption of its expression results in marked im-
pairment of liver regeneration in response to partial hepa-
tectomy.66 Furthermore, unoperated, bile acidefed mice
exhibit increased hepatocellular mitoses and hepatomeg-
aly.66 These observations suggest that the proportionately
increased enterohepatic delivery of bile acids to the post-
resection liver remnant might link altered metabolism to
initiation of liver regeneration. However, hepatic bile acid
content declines after partial hepatectomy in wild-type
mice.66 FXR is expressed in both liver and intestine,
raising a related question as to whether disruption of hepatic
or intestinal expression (or both) is responsible for impaired
regeneration in global FXR-null animals. Recent studies
using tissue-speciﬁc FXR-deleted mice showed that both
liver- and intestine-speciﬁc FXR-null mice exhibit impaired
regeneration in response to resection- and toxin-induced
regenerative stimuli.67,68 However, it is not clear if global
FXR-null mice or either of the tissue-speciﬁc knockout
models is resistant to the hepatomegaly-inducing effects of
enteral bile acids. Intestinal FXR affects bile acid homeo-
stasis in mice by inducing intestinal epithelial expression of
ﬁbroblast growth factor 15 (FGF-15), which is transported via
portal circulation to the liver, where it suppresses bile acid
synthesis.69 Interestingly, FGF-15enull mice were recently
reported to exhibit both impaired resection-induced hepatic
regeneration and reduced enteral bile acidestimulated hepa-
tomegaly.70 These data implicate FXR, FGF-15, and enter-
ohepatic circulation of bile acids in the metabolic regulation
of liver regeneration.
Other Xenobiotic-Activated Nuclear Receptors
Mice also develop hepatomegaly when treated with CAR-
and pregnane X receptor (PXR)eactivating ligands, such
as phenobarbitol, TCPOBOP, and pregnenolone-16a-The American Journal of Pathology - ajp.amjpathol.orgcarbonitrile.53,71 Although these chemically induced re-
sponses are dependent on expression of CAR or PXR,
respectively,55,72 the corresponding null mice show only
modestly impaired liver regeneration after partial hepa-
tectomy.66,73 Whether naturally occurring metabolite li-
gands of CAR or PXR accumulate in regenerating liver
remains unknown. Other xenobiotic-activated nuclear re-
ceptor transcription factors might negatively regulate
liver regeneration. For example, PPARg-null mice exhibit
mildly accelerated regeneration,74 and pharmacological
activation of PPARg75 or LXR76 suppresses regeneration.
Unsaturated fatty acids, eicosanoids, and prostaglandins,
which themselves affect liver regeneration, are naturally
occurring PPARg ligands,77,78 whereas oxysterols are
endogenous ligands for LXR.76 A recent study also sug-
gested that glucose itself might directly regulate LXR ac-
tivity.79 These data reenforce the intriguing, but unproved,
hypothesis that hepatic insufﬁciencyeinduced alterations
in hepatocellular metabolite levels affect liver regeneration
by regulating xenobiotic-activated transcription factor ac-
tivities (Figure 3).
Metabolically Regulated Extrahepatocellular and
Intrahepatocellular Regenerative Signals
Many signaling molecules and pathways implicated in the
regulation of liver regeneration are inﬂuenced by meta-
bolism. However, the speciﬁc metabolic regulation of such
signals during liver regeneration has generally not been
established. Although it is beyond space constraints to con-
sider all such examples herein, several provocative candidates
are discussed.
EGF-R Data
Epidermal growth factor receptor (EGF-R) ligands are
essential humoral regulators of hepatocellular proliferation
in experimental models of liver regeneration.1e3 In other
models, hyperglycemia impairs EGF-R expression and ac-
tivity,80,81 suggesting that disruption of EGF-Redependent
signaling might contribute to the inhibitory effect of glucose
supplementation on liver regeneration20; conversely, partial
hepatectomyeinduced hypoglycemia might promote such
signaling (Figure 3).
GSK-3 Data
Glycogen synthase kinase (GSK)-3, encoded by two related
genes (GSK-3a andGSK-3b), was originally identiﬁed based
on and is named for its ability to phosphorylate glycogen
synthase.82 Such phosphorylation inactivates glycogen syn-
thase activity, and inhibition of GSK-3 activity augments
hepatic glycogen synthesis and improves glucose homeosta-
sis in rodents.82 Analyses of tissue- and isoform-speciﬁc
functions of GSK-3 show that global disruption of GSK-3a
expression, like pharmacological GSK-3 inhibition, aug-
ments murine insulin sensitivity and hepatic glucose meta-
bolism in a mouse strainespeciﬁc manner.83,84 Moreover,315
Huang and Rudnickmuscle-speciﬁc, but not liver-speciﬁc, disruption of GSK-3b
also improves insulin sensitivity.85 Nevertheless, these data
establish the biological role of GSK-3 in glycemic control.
Recent reports also demonstrate that pharmacological inhi-
bition of GSK-3 activity or genetic suppression of GSK-3b
expression inhibits liver regeneration.86e88 Together, these
observations raise the possibility that GSK-3 might link he-
patic insufﬁciencyeinduced hypoglycemia to initiation of
liver regeneration (Figure 3). Consistent with this consider-
ation, GSK-3 also phosphorylates and, thereby, regulates
proteins other than glycogen synthase, including transcription
factors and cell cycle regulators involved in liver regenera-
tion.82 For example, C/EBPa is phosphorylated and inacti-
vated by GSK-3, and an age-dependent decline in GSK-3b
expression was reported to contribute to the reduced
resection-induced regenerative capacity of older livers by
disrupting such regulation.88 As noted previously, hepatic C/
EBPa expression is also augmented in glucose-supplemented
animals subjected to partial hepatectomy.20 Thus, suppression
ofGSK-3 activitymight contribute to impaired regeneration in
glucose-supplemented animals. GSK-3edependent phos-
phorylation and degradation of the Snail transcription factor
has been proposed as another mechanism by which GSK-3b
might promote liver regeneration.87 Despite these consider-
ations, it is difﬁcult to reconcile the expected positive effects
of partial hepatectomyeinduced hypoglycemia on GSK-3
activation (Figure 3) with GSK-3’s recognized effects on
other signaling pathways known to positively regulate liver
regeneration. For example, b-catenin promotes liver regener-
ation89,90 but is targeted for proteasomal degradation byGSK-
3edependent phosphorylation.82 These observations suggest
that distinct subcellular pools of GSK-3 exist, with the pool
responsive to glycemic alterations and involved in promoting
liver regeneration distinct from that which controls b-catenin
degradation. Experimental models of liver regeneration might
offer the opportunity to test this prediction.
mTORC Data
Mammalian target of rapamycin (mTORC), an intracellular
protein complex composed of mTOR, regulatory-associated
protein of TOR, and other proteins, integrates growth
factoredependent signals, together with nutrient and energy
status, to control protein synthesis.91 Activated mTORC
promotes translation through phosphorylation of p70-S6
kinase 1 and eukaryotic initiation factor 4E binding protein.
Amino acid availability, particularly that of leucine and other
BCAAs, affects the ability of mTORC to interact with and
phosphorylate its substrates.91 Interestingly, pharmacolog-
ical inhibition of mTOR suppresses cyclin D1 expression and
hepatocellular proliferation in mice subjected to partial hep-
atectomy.92,93 These data suggest a mechanism by which the
metabolic response to hepatic insufﬁciency, and the accom-
panying hepatic accumulation of BCAA, might promote
proregenerative hepatic protein expression. Indeed, this
consideration is consistent with the previously mentioned
beneﬁcial effect of supplemental BCAA on liver regeneration316noted in various studies.47 Growth factoredependent activa-
tion of phosphoinositide-3 kinase/Akt signaling also stimu-
lates mTORC activity91 and promotes liver regeneration.94e96
However, those ﬁndings seem contradictory to data indicating
that mTORC activity is negatively regulated by the energy-
sensitive AMP-activated protein kinase (AMPK91). This
latter observation predicts that the declining ratio of ATP/
AMP in regenerating liver, which should activate AMPK,
would inactivate mTOR; however, decreased ATP/AMP has
also been suggested as important for progression of regener-
ation.29Moreover, AMPK itself was recently implicated in the
positive regulation of liver regeneration.97 Perhaps the
threshold level of ATP/AMP that triggers AMPK’s inhibitory
action on mTORC is below that which is crossed after partial
hepatectomy to promote liver regeneration. Again, further
study is needed to clarify these considerations.
Metabolic Inﬂuences on Epigenetic Regulation
A provocative, but unproved, idea is that alterations in meta-
bolism inﬂuence liver regeneration by affecting epigenetic
changes in histone protein acetylation. Indirect support for this
hypothesis comes from data showing that glucose supple-
mentation promotes histone protein acetylation in mammalian
cell culture, with fatty acids unable to substitute for glucose in
those models.98,99 Thus, partial hepatectomyeinduced alter-
ations in glycemia might inﬂuence histone acetylation by
reducing histone acetyltransferase acetyl-CoA substrate
availability. Relevant to these points, total hepatic zinc-
dependent histone deacetylase (Zn-HDAC) activity was
recently reported to increase and global liver histone acetyla-
tion was reported to decrease in parallel with onset of hy-
poglycemia after partial hepatectomy.100 The functional
importance of Zn-HDAC activity was demonstrated by
showing that suberoylanilide hydroxamic acid, a global in-
hibitor of Zn-HDACactivity, suppresses liver regeneration.100
The possibility of metabolic regulation of hepatic Zn-HDAC
activity during liver regeneration was also suggested by data
showing thatHDAC5, a class IIaZn-HDACwhose subcellular
localization is regulated by glycemia,101 undergoes nuclear
localization in response to partial hepatectomy.100 A recent
report identiﬁed the ketone body, b-hydroxybutyrate, as a
potent inhibitor of speciﬁc Zn-HDACs in vivo,102 raising the
possibility that other endogenous metabolites that accumulate
in regenerating liver as part of the metabolic response to he-
patic insufﬁciency might have similar activity (Figure 3).
Finally, SIRT1, a class III (ie, sirtuin) NAD-dependent
HDAC, was recently shown to be essential for normal liver
regeneration.103 Together, these data suggest that altered
metabolism might affect liver regeneration via epigenetic
regulation of histone (and nonhistone protein) acetylation.
Metabolic alterations might also inﬂuence patterns of DNA
methylation in regenerating liver. This consideration is
particularly intriguing in the context of the previously men-
tioned impairment of liver regeneration observed in MAT1A
knockout mice.43 Biosynthesis of SAMe, which serves as aajp.amjpathol.org - The American Journal of Pathology
Metabolism and Liver Regenerationmethyl donor in DNA methylation reactions, is catalyzed by
MAT1A, and hepatic SAMe levels are reduced in MAT1A-
null mice.104 Corroborating evidence for the functional
importance of regulated changes in DNAmethylation patterns
during liver regeneration is suggested by older studies
showing that azacytidine, which inhibits DNA methyl-
transferase activity, suppresses regeneration under certain
circumstances.105 Finally, one additional but highly specula-
tive point regarding the potential relationships between
metabolism, DNA methylation, and regenerative hepatocel-
lular proliferation should bementioned:mutations in isocitrate
dehydrogenase, which catalyzes the production of a-keto-
glutarate in the Kreb’s cycle, have recently been identiﬁed in
myeloid leukemia and other cancers.106 a-Ketoglutarate also
serves as a cofactor for DNA (cytosine) demethylation re-
actions,107 and cancer patients with isocitrate dehydrogenase
mutations exhibit global promoter hypermethylation.106
a-Ketoglutarate is also the amino group acceptor for the re-
action, catalyzed by alanine aminotransferase, which is highly
expressed in liver and produces the gluconeogenic precursor,
pyruvate, from alanine. Thus, alterations in the level of
a-ketoglutarate, which likely occur together with the changes
in glycolytic and gluconeogenic ﬂux in regenerating liver,
could affect patterns of DNA methylation via the mechanism
discussed above. Nevertheless, the pattern, regulation, and
functional importance of changes in hepatic DNAmethylation
during liver regeneration require further examination.
A Metabolic Model of Liver Regeneration
Together, the data and considerations discussed here support a
metabolic model of liver regeneration in which alterations in
metabolism that occur in response to hepatic insufﬁciency
provide energy and macromolecular precursors necessary for
regeneration and generate speciﬁc molecular signals that
initiate regenerative hepatocellular proliferation. Future studies
should test the predictions suggested by this model (Figure 3).
Clinical Implications
Metabolic inﬂuences on hepatic regenerative capability have
obvious potential relevance to human health. For example,
the impairment of liver regeneration in experimental models
of fatty liver disease, aging, fulminant liver failure, and
other processes might be related to the perturbations in
normal metabolism that accompany such conditions. These
topics are brieﬂy considered herein.
Fatty Liver
Unlike the transient steatosis that occurs during the normal
regenerative response to hepatic insufﬁciency,26 chronic
hepatic steatosis is associated with impaired resection- and
toxin-induced liver regeneration in many, but not all,
experimental models.19 Those studies suggest that the
magnitude of hepatic steatosis is important in determining itsThe American Journal of Pathology - ajp.amjpathol.orgeffect on liver regeneration. Chronic steatosis is also linked to
adverse outcomes after liver resection in humans.108 Taken
together with the considerations raised herein, these data
suggest that acute versus chronic hepatic steatosis, and
accompanying differences in hepatic and systemic meta-
bolism, likely exert distinct effects on growth factor, sec-
ondary messenger, genetic, and epigenetic signals and,
thereby, have divergent inﬂuences on liver regeneration.
Nevertheless, the speciﬁc mechanisms responsible remain
enigmatic and require further investigation.
Aging
The aged liver has reduced regenerative capacity in response to
resection. Although long recognized,109 the mechanisms
responsible remain incompletely deﬁned. As already noted,
speciﬁc anti-proliferative factors whose hepatic expression is
induced in association with impaired regeneration in glucose-
supplemented mice, including C/EBPa and p21Cip1,20 are also
up-regulated in post-resection livers from aged animals.110 Thus,
age-related effects on glycemia might contribute to the impair-
ment of partial hepatectomyeinduced liver regeneration in old
animals. Further support for this idea comes from data impli-
cating effects on Zn-HDACs in the anti-regenerative inﬂuence
of aging,110 together with the previously mentioned study sug-
gesting that metabolism inﬂuences Zn-HDAC expression, ac-
tivity, and subcellular localization during liver regeneration.100
Surprisingly, old age does not suppress the hepatocellular pro-
liferative response to certain toxins6 or xenobiotics (eg,
TCPOBOP111). The relevance of these data to human liver
regeneration requires further investigation. In particular, whether
diminished resection-induced regeneration of the aged liver
contributes to reduced survival of transplanted liver grafts from
older donors reported in some studies110 should be examined.
Subtotal Hepatic Resection
Published experimental analyses in which 85% to 90% of the
native liver is resected (ie, subtotal hepatectomy) show delayed
liver regeneration and increased mortality.33 Those observa-
tions suggest the existence of a threshold amount of remnant
liver mass below which regenerative recovery is inefﬁcient.
Unlike the effect on regeneration after two-thirds partial hep-
atectomy, glucose supplementation improves the outcomes
from experimental subtotal hepatectomy.32 The mechanisms
responsible for these seemingly discordant effects of glycemia
on the response to partial versus subtotal hepatectomy are
entirely unknown. Elucidating those mechanisms might
inform strategies to improve clinical management of patients
with ALF and SFSS, for which subtotal hepatectomy in ro-
dents has been used as an experimental model.
Metabolomic Biomarkers of Human Liver Regeneration
The considerations raised herein also suggest that
metabolomic serum biomarkers of experimental liver317
Huang and Rudnickregeneration could permit more reliable, noninvasive
assessment of human liver regeneration. Such tools would
be especially useful in the clinical management of ALF
and when there is concern for SFSS. ALF is a potentially
devastating condition from which some patients die or
undergo liver transplantation.112 Others recover sponta-
neously, based in part on adequate regeneration of the
liver. However, an early reliable distinction between those
patients with ALF most likely to survive spontaneously
and those at increased risk of death without liver trans-
plantation remains extremely challenging.112 Similarly,
predicting spontaneous regenerative recovery in patients at
risk of SFSS is difﬁcult.33 The novel metabolic model of
liver regeneration proposed herein (Figure 3) predicts that
speciﬁc patterns of change in circulating metabolites might
distinguish progression of normal liver regeneration from
an impaired response. Proof of principle for that idea was
provided by the recent identiﬁcation of Aab, mentioned
earlier, as a sensitive and speciﬁc humoral biomarker
of mouse liver regeneration, followed by subsequent
demonstration of a signiﬁcant correlation between serum
Aab levels and spontaneous survival in a pilot analysis of
pediatric patients with ALF.28 Nonetheless, additional
studies are needed to further characterize the humoral
metabolomic signature of experimental liver regeneration
and deﬁne its value in the evaluation and management of
human liver disease.
Summary and Conclusions
Many studies implicate alterations in metabolism in
response to experimentally induced hepatic insufﬁciency
(Figure 1) as functionally important for normal liver
regeneration (Figure 2). Such analyses also suggest
candidate molecular mechanisms by which such linkage
might occur (Figure 3). Together, these data support a
metabolic model of liver regeneration in which the essence
of the hepatostat is deﬁned by hepatic metabolic function.
Future research should interrogate the unique functional
relationships between speciﬁc alterations in metabolism
and individual signaling pathways during liver regeneration
and investigate whether derangement of these interactions
causes impaired liver regeneration in fatty liver disease, old
age, ALF, SFSS, and perhaps other conditions. Ultimately,
such work could lead to the development of pro-
regenerative nutritional and metabolism-based strategies
and more reliable, noninvasive, metabolomic biomarkers of
liver regeneration to improve the management of human
liver disease.
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